BMC Gastroenterology · Aug 6, 2026

Baseline atherogenic coefficient and risk of incident chronic liver disease: a prospective cohort study from the CHARLS

By Dong J, Guo G, Meng T et al.

BACKGROUND: Chronic liver disease (CLD) is a major public health burden, particularly among middle-aged and older adults. The atherogenic coefficient [(TC - HDL-C)/HDL-C]is a simple lipid-derived index widely used in metabolic risk assessment, but its longitudinal association with incident CLD remains unclear. OBJECTIVE: To investigate the longitudinal association between the atherogenic coefficient [(TC - HDL-C)/HDL-C]and the risk of incident chronic liver disease among middle-aged and older adults using data from the China Health and Retirement Longitudinal Study (CHARLS). METHODS: This prospective cohort study used data from the China Health and Retirement Longitudinal Study (CHARLS). A total of 6,721 participants aged ≥ 45 years without CLD at baseline (2011) were followed through 2020. The atherogenic coefficient was analyzed as both a continuous and categorical variable. Cox proportional hazards models were applied to assess associations with incident CLD, and restricted cubic spline models were used to explore nonlinear dose-response relationships. RESULTS: Among the 6721 participants, 552 participants (8.2%) developed chronic liver disease. Higher baseline atherogenic coefficient was associated with an increased risk of incident CLD. In fully adjusted Cox models, participants in the high atherogenic coefficient group had a significantly higher risk of CLD compared with those in the low-risk group (hazard ratio [HR] = 1.56, 95%CI-1.17-2.06; p = 0.002). Restricted cubic spline analyses suggested an overall positive association between the atherogenic coefficient and incident CLD, with the lowest estimated risk observed around an atherogenic coefficient of approximately 3 and a tendency toward higher risk at higher atherogenic coefficient levels (p for overall < 0.001). Subgroup analyses showed broadly consistent associations across examined subpopulations. CONCLUSIONS: A higher baseline atherogenic coefficient may be associated with an increased risk of incident chronic liver disease among middle-aged and older Chinese adults.

doi.org/10.1186/s12876-026-05176-8Open accessPubMed 42977888Biomarkers

AgingResearch.News